CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study.

MLA

Rozental, Alon, et al. “CML in the Very Elderly: The Impact of Comorbidities and TKI Selection in a Real-Life Multicenter Study.” Annals of Hematology, vol. 103, no. 9, Sept. 2024, pp. 3585–94. EBSCOhost, https://doi.org/10.1007/s00277-024-05828-3.

APA

Rozental, A., Halperin, E., Leibovitch, C., Barzili, M., Michowitz, M. K.-, Duek, A., Rozovski, U., Extermann, M., Raanani, P., & Shacham-Abulafia, A. (2024). CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study. Annals of Hematology, 103(9), 3585–3594. https://doi.org/10.1007/s00277-024-05828-3

Chicago

Rozental, Alon, Erez Halperin, Chiya Leibovitch, Meirav Barzili, Maya Koren- Michowitz, Adrian Duek, Uri Rozovski, Martine Extermann, Pia Raanani, and Adi Shacham-Abulafia. 2024. “CML in the Very Elderly: The Impact of Comorbidities and TKI Selection in a Real-Life Multicenter Study.” Annals of Hematology 103 (9): 3585–94. doi:10.1007/s00277-024-05828-3.